Clinical Trials Browser

Leukemia, Myeloid, Acute × tocilizumab × Clear all

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT04580121 2024-06-03

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Phase 1 Completed

59 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04547062 2023-04-28

Tocilam

Phase 1 Completed

12 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02057770 2018-10-12

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Terminated

25 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Clinical Trials

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

A Dose Escalation and Expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7283420.

Tocilam

Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia